Albano L et al. |
OSAKA trial: a randomized, controlled trial comparing tacrolimus QD and BD in kidney transplantation. |
2013 |
Transplantation |
pmid:23982340
|
Fredericks S et al. |
Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements. |
2006 |
Transplantation |
pmid:16969296
|
Marcos A et al. |
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. |
2004 |
Transplantation |
pmid:15480160
|
Rolles K et al. |
A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin. |
1999 |
Transplantation |
pmid:10551650
|
Pirsch JD |
Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: results of the U.S. multicenter FK506 Kidney Transplant Study Group. |
1999 |
Transplantation |
pmid:10551653
|
Lee D et al. |
Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression. |
2017 |
Transplantation |
pmid:27779572
|
Sugitani A et al. |
En bloc pancreas and kidney transplantation in a patient with limited vascular access. |
1997 |
Transplantation |
pmid:9197366
|
Wozniak LJ et al. |
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. |
2015 |
Transplantation |
pmid:26038872
|
Bayer ND et al. |
Association of metabolic syndrome with development of new-onset diabetes after transplantation. |
2010 |
Transplantation |
pmid:20724958
|
Boldt A et al. |
The influence of immunosuppressive drugs on T- and B-cell apoptosis via p53-mediated pathway in vitro and in vivo. |
2006 |
Transplantation |
pmid:16906043
|
Lawsin L and Light JA |
Severe acute renal failure after exposure to sirolimus-tacrolimus in two living donor kidney recipients. |
2003 |
Transplantation |
pmid:12544890
|
Furukawa H et al. |
Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs. |
2000 |
Transplantation |
pmid:10670633
|
Gaber AO et al. |
Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal. |
2013 |
Transplantation |
pmid:23423269
|
Mañez R et al. |
Fluconazole therapy in transplant recipients receiving FK506. |
1994 |
Transplantation |
pmid:7515201
|
Jordan ML et al. |
Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. |
2000 |
Transplantation |
pmid:10670637
|
Guethoff S et al. |
Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation. |
2013 |
Transplantation |
pmid:23423270
|
Furukawa H et al. |
The effect of bile duct ligation and bile diversion on FK506 pharmacokinetics in dogs. |
1992 |
Transplantation |
pmid:1373531
|
Sakr M et al. |
Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients. |
1992 |
Transplantation |
pmid:1373535
|
Hirano Y et al. |
Morphological and functional changes of islets of Langerhans in FK506-treated rats. |
1992 |
Transplantation |
pmid:1373536
|
Hoffman AL et al. |
The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. |
1990 |
Transplantation |
pmid:1690469
|
Miyakoshi S et al. |
Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases. |
2007 |
Transplantation |
pmid:17700155
|
Naesens M et al. |
The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide. |
2007 |
Transplantation |
pmid:17700162
|
Yasunami Y et al. |
FK506 as the sole immunosuppressive agent for prolongation of islet allograft survival in the rat. |
1990 |
Transplantation |
pmid:1691535
|
Huang E et al. |
Alemtuzumab induction in deceased donor kidney transplantation. |
2007 |
Transplantation |
pmid:17984833
|
Kato T et al. |
Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year. |
2007 |
Transplantation |
pmid:17984834
|
Ravindran VK et al. |
Insulin hyposecretion in nondiabetic, tacrolimus-treated renal transplant recipients more than 6 months posttransplantation. |
2009 |
Transplantation |
pmid:19543067
|
Jain A et al. |
Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus. |
2000 |
Transplantation |
pmid:11087149
|
Muthukumar T et al. |
HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles. |
2013 |
Transplantation |
pmid:23503504
|
Tzakis AG et al. |
Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation. |
2003 |
Transplantation |
pmid:12792506
|
Koenen HJ et al. |
Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis. |
2003 |
Transplantation |
pmid:12792519
|
Heilman RL et al. |
Impact of early conversion from tacrolimus to sirolimus on chronic allograft changes in kidney recipients on rapid steroid withdrawal. |
2012 |
Transplantation |
pmid:22067270
|
First MR |
Strategies to minimize immunological and nonimmunological risk factors in the renal transplant population. |
2001 |
Transplantation |
pmid:11585240
|
Koomans HA and Ligtenberg G |
Mechanisms and consequences of arterial hypertension after renal transplantation. |
2001 |
Transplantation |
pmid:11585243
|
Tarumi K et al. |
CTLA4IgG treatment induces long-term acceptance of rat small bowel allografts. |
1999 |
Transplantation |
pmid:10071020
|
Trimarchi HM et al. |
FK506-associated thrombotic microangiopathy: report of two cases and review of the literature. |
1999 |
Transplantation |
pmid:10071024
|
Pirsch JD et al. |
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. |
1997 |
Transplantation |
pmid:9112351
|
Sokal EM et al. |
Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. |
1997 |
Transplantation |
pmid:9392308
|
Tanabe M et al. |
Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation. |
1994 |
Transplantation |
pmid:7518619
|
Khanna AK |
Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus. |
2000 |
Transplantation |
pmid:10972232
|
Königsrainer A et al. |
Nonocclusive segmental mesenteric ischemia after combined pancreas kidney transplantation: mycophenolate mofetil as an etiological factor? |
2000 |
Transplantation |
pmid:10972233
|
Abu-Qaoud MS et al. |
Lack of relationship between microvascular and macrovascular disease in heart transplant recipients. |
2012 |
Transplantation |
pmid:23044666
|
Woodward RS et al. |
Renal graft survival and calcineurin inhibitor. |
2005 |
Transplantation |
pmid:16177637
|
Heilman RL et al. |
Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal. |
2011 |
Transplantation |
pmid:21775930
|
Jevnikar A et al. |
Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure. |
2008 |
Transplantation |
pmid:18852662
|
Yamazaki S et al. |
Transplantation-related thrombotic microangiopathy triggered by preemptive therapy for hepatitis C virus infection. |
2008 |
Transplantation |
pmid:18852671
|
Kiuchi T |
CNIs: immediate benefits but storing problems for the future? |
2008 |
Transplantation |
pmid:18946338
|
Textor SC et al. |
Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. |
1993 |
Transplantation |
pmid:7685934
|
Borrows R et al. |
Five years of steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil. |
2006 |
Transplantation |
pmid:16421488
|
Arzouk N et al. |
Interaction between tacrolimus and fumagillin in two kidney transplant recipients. |
2006 |
Transplantation |
pmid:16421493
|
Kandula P et al. |
Impact of tacrolimus-sirolimus maintenance immunosuppression on proteinuria and kidney function in pancreas transplant alone recipients. |
2012 |
Transplantation |
pmid:23037007
|
Dickenmann MJ et al. |
Blood eosinophilia in tacrolimus-treated patients: an indicator of Pneumocystis carinii pneumonia. |
1999 |
Transplantation |
pmid:10589963
|
Eckhoff DE et al. |
Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation. |
1998 |
Transplantation |
pmid:9458011
|
Roth D et al. |
Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients. |
1998 |
Transplantation |
pmid:9458023
|
First MR et al. |
New-onset diabetes after transplantation (NODAT): an evaluation of definitions in clinical trials. |
2013 |
Transplantation |
pmid:23619735
|
Hadley S et al. |
Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. |
1995 |
Transplantation |
pmid:7535482
|
Alessiani M et al. |
Combined immunosuppressive therapy with tacrolimus and mycophenolate mofetil for small bowel transplantation in pigs. |
1996 |
Transplantation |
pmid:8830816
|
Naesens M and Sarwal MM |
Monitoring calcineurin inhibitor therapy: localizing the moving target. |
2010 |
Transplantation |
pmid:20458272
|
Kaufman DB et al. |
The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome. |
1995 |
Transplantation |
pmid:7541579
|
Thorp M et al. |
The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol. |
2000 |
Transplantation |
pmid:10762229
|
Miyazawa H et al. |
Hamster to rat kidney xenotransplantation. Effects of FK 506, cyclophosphamide, organ perfusion, and complement inhibition. |
1995 |
Transplantation |
pmid:7537396
|
Irish W et al. |
Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen. |
2003 |
Transplantation |
pmid:14688516
|
Fujii Y et al. |
Effect of a novel immunosuppressive agent, FK506, on mitogen-induced inositol phospholipid degradation in rat thymocytes. |
1989 |
Transplantation |
pmid:2472025
|
Chisholm MA et al. |
Coadministration of tacrolimus with anti-acid drugs. |
2003 |
Transplantation |
pmid:12973105
|
Koch R et al. |
Cyclosporine A-induced achalasia-like esophageal motility disorder in a liver transplant recipient: successful conversion to tacrolimus. |
2003 |
Transplantation |
pmid:12973123
|
Dean PG et al. |
Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus. |
2008 |
Transplantation |
pmid:18431244
|
Shoji T et al. |
Operational tolerance to class I disparate lungs can be induced despite pretransplant immunization with class I allopeptides. |
2007 |
Transplantation |
pmid:18091523
|
McDiarmid SV et al. |
Factors affecting growth after pediatric liver transplantation. |
1999 |
Transplantation |
pmid:10030286
|
Shapiro R et al. |
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. |
1999 |
Transplantation |
pmid:10030287
|
Paty BW et al. |
Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. |
2002 |
Transplantation |
pmid:11884930
|
Florescu DF et al. |
Adenovirus infections in pediatric small bowel transplant recipients. |
2010 |
Transplantation |
pmid:20467354
|
Dell'Antonio G and Randhawa PS |
"Striped" pattern of medullary ray fibrosis in allograft biopsies from kidney transplant recipients maintained on tacrolimus. |
1999 |
Transplantation |
pmid:10030300
|
Amundsen R et al. |
Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients. |
2009 |
Transplantation |
pmid:19384170
|
Jun KR et al. |
Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea. |
2009 |
Transplantation |
pmid:19384171
|
Ericzon BG et al. |
Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus. |
1997 |
Transplantation |
pmid:9000664
|
Kelly PA et al. |
Ciprofloxacin does not block the antiproliferative effect of tacrolimus. |
1997 |
Transplantation |
pmid:9000686
|
Ueda M et al. |
A proposal of FK506 optimal dosing in living related liver transplantations. |
1995 |
Transplantation |
pmid:7544035
|
Cantarovich D et al. |
Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events. |
2005 |
Transplantation |
pmid:15714172
|
Fisher A et al. |
FK506 hepatotoxicity in liver allograft recipients. |
1995 |
Transplantation |
pmid:7539961
|
Nguyen L et al. |
Conversion from tacrolimus/mycophenolic acid to tacrolimus/leflunomide to treat cutaneous warts in a series of four pediatric renal allograft recipients. |
2012 |
Transplantation |
pmid:22960763
|
Vafadari R et al. |
Pharmacodynamic analysis of tofacitinib and basiliximab in kidney allograft recipients. |
2012 |
Transplantation |
pmid:22960764
|
Stevens C et al. |
The effects of immunosuppressive agents on in vitro production of human immunoglobulins. |
1991 |
Transplantation |
pmid:1710843
|
Thomas PG et al. |
Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation. |
2007 |
Transplantation |
pmid:17565326
|
MacDonald A |
Improving tolerability of immunosuppressive regimens. |
2001 |
Transplantation |
pmid:11833142
|
Wang K et al. |
Transplantation of infantile bladder in rats: an alternative procedure for bladder augmentation. |
2001 |
Transplantation |
pmid:11213059
|
Mollevà DG et al. |
Heart and liver xenotransplantation under low-dose tacrolimus: graft survival after withdrawal of immunosuppression. |
2001 |
Transplantation |
pmid:11213062
|
Gruessner RW et al. |
Donor-specific portal blood transfusion in intestinal transplantation: a prospective, preclinical large animal study. |
1998 |
Transplantation |
pmid:9701258
|
Pascual J et al. |
Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial. |
2010 |
Transplantation |
pmid:20335831
|
Raggi MC et al. |
Customized mycophenolate dosing based on measuring inosine-monophosphate dehydrogenase activity significantly improves patients' outcomes after renal transplantation. |
2010 |
Transplantation |
pmid:21076373
|
Sahara H et al. |
Beneficial effects of perioperative low-dose inhaled carbon monoxide on pulmonary allograft survival in MHC-inbred CLAWN miniature swine. |
2010 |
Transplantation |
pmid:21076382
|
Schvarcz R et al. |
Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV). |
2000 |
Transplantation |
pmid:10852623
|
Tsugita M et al. |
Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model. |
1996 |
Transplantation |
pmid:8685952
|
Kuypers DR et al. |
Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. |
2013 |
Transplantation |
pmid:23263559
|
Lake JR et al. |
The impact of immunosuppressive regimens on the cost of liver transplantation--results from the U.S. FK506 multicenter trial. |
1995 |
Transplantation |
pmid:7482713
|
Mathew A et al. |
Reversal of steroid-resistant rejection in renal allograft recipients using FK506. |
1995 |
Transplantation |
pmid:7482730
|
Stephen M et al. |
Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK-506 in the rat. A comparative and combination study with cyclosporine. |
1989 |
Transplantation |
pmid:2463701
|
White M et al. |
Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus. |
2006 |
Transplantation |
pmid:17006323
|
Wissing KM et al. |
Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation. |
2006 |
Transplantation |
pmid:17006324
|
Gruessner RW et al. |
Over 500 solitary pancreas transplants in nonuremic patients with brittle diabetes mellitus. |
2008 |
Transplantation |
pmid:18192910
|
Fuchinoue S et al. |
Kidney transplantation after liver transplantation from the same donor: four cases of successful steroid withdrawal. |
2002 |
Transplantation |
pmid:11923698
|
Lauzurica R et al. |
Tacrolimus-associated severe bilateral corneal ulcer after renal transplantation. |
2002 |
Transplantation |
pmid:11923710
|